Skip to main content
FinSpry Logo
FinSpry
ORMP logo
ORMP
(NASDAQ)
Oramed Pharmaceuticals Inc.
$4.28-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Oramed Pharmaceuticals (ORMP) Stock Price & Financial Analysis

Oramed Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.18 - $4.35
52-Week High$5.01
52-Week Low$1.98
Open$4.25
Volume149.28K
Average Volume (3M)171.60K
Market Cap183.67M
Shares Outstanding42.42M
P/E Ratio (TTM)2.87
Price to Sales (P/S)91.84
Price to Book (P/B)0.92
EV/EBITDA2.22
Revenue (TTM)2.00M
Net Income (TTM)64.05M
Free Cash Flow (TTM)-9.16M
EPS (TTM)$1.52
Profit Margin3202.50%
Operating Margin-754.40%
Return on Equity (ROE)32.07%
Debt to Equity0.00
50-Day MA$3.67
200-Day MA$2.93
52-Week Change106.25%
Annual Dividend$0.25
Dividend Yield5.84%
Payout Ratio16.49%
Last Dividend Ex-DateJan 16, 2026

Frequently Asked Questions About Oramed Pharmaceuticals

What is the current stock price for ORMP?

As of the latest trading session, ORMP stock trades at $4.28. The 52-week range is $1.98–$5.01, with a day range of $4.18–$4.35.

What is the P/E ratio for ORMP?

Oramed Pharmaceuticals's trailing P/E ratio is 2.9, meaning investors pay $2.9 for every $1 of annual earnings. Oramed Pharmaceuticals operates in the Healthcare sector.

Does ORMP pay dividends?

Yes, Oramed Pharmaceuticals pays a 5.84% annual dividend yield ($0.25 per share). The payout ratio is 16.5%. The last ex-dividend date was 2026-01-16.

What do analysts recommend for ORMP?

Analyst ratings and recommendations for ORMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ORMP?

Oramed Pharmaceuticals's market capitalization is $181.6M, classifying it as a micro-cap company. Oramed Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.